Navigation Links
Continued Funding to Help Advance 'Exciting Moment' in Diabetes Research
Date:4/30/2008

American Diabetes Association and Richard and Susan Smith Family Foundation Announce Renewed Commitment to Diabetes Gene Study

ALEXANDRIA, Va., April 30 /PRNewswire-USNewswire/ -- The American Diabetes Association (ADA) has announced research projects to study newly discovered human type 2 diabetes genes in mice, and potentially find new drug molecules that can treat the genetic causes of type 2 diabetes. The projects will be funded through a renewed partnership -- between the ADA/Richard and Susan Smith Family Foundation Pinnacle Program Project Award -- of more than $2 million over three years.

Evan Rosen, MD, PhD, of Beth Israel Deaconess Medical Center in Boston, and Vamsi K. Mootha, MD, of Harvard University are lead researchers for the grant projects. Dr. Rosen's study Humanized Mouse Models of Type 2 Diabetes will focus on whether mouse models with human diabetes genes will have beneficial effects on glucose control. Dr. Mootha's project Cellular Models of Human Type 2 Diabetes Genes will study whether markers can be established to monitor therapeutic responses. This grant will expand on the foundation that the first Pinnacle Program Project, Systematic identification of pathways contributing to diabetes and obesity, set forth.

Research from the Foundation's initial grant led to the discovery of five new genes associated with type 2 diabetes, as well as one for obesity and one for triglyceride levels (a component of blood cholesterol). The discoveries were found with the use of a new and powerful approach to diabetes research developed based on contributions by the group, whole genome association studies (WGAS).

"The discoveries of these researchers have contributed greatly to our knowledge of genes influencing diabetes and to a lesser extent obesity," commented Cathy Bernstein, Chair, ADA Research Foundation. "The novel genes identified by this approach were completely unexpected from previous knowledge, and have opened up new windows into the biology of these diseases."

"This is a truly exciting moment, with great possibilities for building and expanding on these successes," commented Scott Campbell, ADA Vice President of Research. "These newly discovered genes provide leads that must be followed to decipher the causes of type 2 diabetes and to obtain clues for improving prevention and treatment."

The Richard and Susan Smith Family Foundation Pinnacle Program Project Award was established to stimulate new collaborations among investigators working on independent but complementary research projects aimed at developing methods of preventing type 2 diabetes.

About the American Diabetes Association

The American Diabetes Association is the nation's premier voluntary health organization supporting diabetes research, information and advocacy. Founded in 1940, the Association has offices in every region of the country, providing services to hundreds of communities. The Association's commitment to research is reflected through its scientific meetings; education and provider recognition programs; and its Research Foundation and Nationwide Research Program, which fund breakthrough studies looking into the cure, prevention, and treatment of diabetes and its complications. The American Diabetes Association Research Foundation was created to raise support for diabetes research conducted within the Nationwide Research Program. One hundred percent of all Research Foundation contributions go directly to diabetes research. All non-research costs associated with the Research Program are paid for through the Association's general fund.

For more information, please visit http://www.diabetes.org or call 1-800-DIABETES (1-800-342-2383). Information from both these sources is available in English and Spanish.


'/>"/>
SOURCE American Diabetes Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
3. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
4. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
5. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
6. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
7. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
8. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
9. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
10. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
11. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... -- The Global Effective Microorganisms (EM) Market by ... covered and analysed the potential of Global Effective Microorganisms (EM) ... and growth factors. The report identifies and analyses the emerging ... global market. ... Tables and Figures, 6 Major Company Profiles, spread across 124 ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps ... fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization GenCure, ... at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood donations ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB since ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... Bill ... management industry in the coastal communities. After Tina Howe joined the team, the Bill ... happy employees, honest services at affordable rates, and giving back to the San Diego ...
Breaking Medicine News(10 mins):